Navigation Links
Amarna Therapeutics B.V. and TNO announce SVac research and development partnership
Date:6/9/2009

Leiden, The Netherlands, June 09, 2009 / b3c newswire / - Dutch biotechnology company Amarna Therapeutics B.V. and the Netherlands Organisation for Applied Scientific Research TNO today announced that they have entered into a collaboration agreement to further develop Amarna’s viral gene delivery platform SVac. Under this agreement, TNO will develop novel methods for the manufacture, formulation and testing of viral gene delivery systems such as the SVac platform of Amarna. The collaboration is partly supported by a co-financing initiative aimed at developing innovative technologies.

“We are very pleased to work with TNO”, said Ben van Leent, CEO of Amarna Therapeutics. “We have developed a revolutionary novel viral gene delivery vector platform technology SVac for producing human therapeutics that have the potential to save lives and improve the quality of life for millions of people worldwide that are suffering from life-threatening or severe chronic diseases. The technology is now available to address the major diseases of our time including genetic disorders, autoimmune diseases, allergies and cancer. Amarna Therapeutics acts at the forefront of the therapeutic vaccination and gene therapy markets. Both markets are rapidly growing to reach an estimated 40 billion Euro’s in 2015. I’m convinced that the therapeutics in our pipeline all have blockbuster potential. The partnership with TNO enables us to initiate the first time in man clinical trials with one of our lead therapeutics in 2010.”

“The partnership between TNO and Amarna allows us to expand our pre-clinical development services into the extremely important therapeutic area of viral vector and gene delivery techno
'/>"/>

b3c newswire

0

GOOD

Page: 1 2 3

Related biology news :

1. Continuous glucose monitoring technology -- special issue of Diabetes Technology and Therapeutics
2. NIH announces new program to develop therapeutics for rare and neglected diseases
3. Ocera Therapeutics licenses novel treatment for acute hepatic encephalopathy from UCLB
4. Tufts University professor receives IADR Pharmacology/Therapeutics/Toxicology Award
5. Acorda Therapeutics submits new drug application for Fampridine-SR in multiple sclerosis
6. A novel target for therapeutics against Staph infection
7. Bayhill Therapeutics and the Juvenile Diabetes Research Foundation announce research collaboration
8. Growing fuel and medicine: Advancing biofuels and plant-produced therapeutics
9. Sirtris review of sirtuin therapeutics for diseases of aging in Nature Reviews Drug Discovery
10. Media invitation: 20th EORTC-NCI-ACR Symposium on Molecular Targets and Cancer Therapeutics
11. CU-Boulder, biotech firm team up on python project in search for human cardiac therapeutics

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... , The presence of increased body fat, and ther...the blood, hinders the loss and maintenance of bod...iversity of Navarra conducted by Estbaliz Goyenech... The project, entitled "A nutrigenetic and nutrig...ight and inflammation," examines how the individua...
(Date:11/23/2009)...strain of the deadly superbug MRSAan infection-cau...poses a far greater health threat than previously ...ing to a study in the December issue of Emerging ...y picked up in fitness centers, schools, and other...n of MRSA within hospitals, the report found. , ...
(Date:11/23/2009)...day matters to forest trees dealing with drought, ...am led by Professor Malcolm Campbell, University o...h and colleagues in the department of cell and sys...alizing on their previous work to decode the genom...ow poplar trees use their 45,000 genes to respond ...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2New study finds MRSA on the rise in hospital outpatients 2Time of day matters to thirsty trees, U of T researcher discovers 2Reportlinker Adds World Cancer Therapies Market Report 56747 1Reportlinker Adds World Cancer Therapies Market Report 56747 2Reportlinker Adds World Cancer Therapies Market Report 56747 3Reportlinker Adds World Cancer Therapies Market Report 56747 4Reportlinker Adds World Cancer Therapies Market Report 56747 5Reportlinker Adds World Cancer Therapies Market Report 56747 6Reportlinker Adds World Cancer Therapies Market Report 56747 7Reportlinker Adds World Cancer Therapies Market Report 56747 8Reportlinker Adds World Cancer Therapies Market Report 56747 9Reportlinker Adds World Cancer Therapies Market Report 56747 10Reportlinker Adds World Cancer Therapies Market Report 56747 11Reportlinker Adds World Cancer Therapies Market Report 56747 12Reportlinker Adds World Cancer Therapies Market Report 56747 13Reportlinker Adds World Cancer Therapies Market Report 56747 14Reportlinker Adds World Cancer Therapies Market Report 56747 15Esperance Pharmaceuticals Announces Initiation of Clinical Studies of its Novel Membrane disrupting Agent EP 100 in Patients with Cancer 13972 1Esperance Pharmaceuticals Announces Initiation of Clinical Studies of its Novel Membrane disrupting Agent EP 100 in Patients with Cancer 13972 2Esperance Pharmaceuticals Announces Initiation of Clinical Studies of its Novel Membrane disrupting Agent EP 100 in Patients with Cancer 13972 3Wings of Mercy Benefit Features Miracle on the Hudson Heroes 56743 1Wings of Mercy Benefit Features Miracle on the Hudson Heroes 56743 2Wings of Mercy Benefit Features Miracle on the Hudson Heroes 56743 3
...ic gene mutation may be useful in predicting the l...e treatment options and follow-up care, according ...AF V600E, is a genetic alteration in the BRAF onco...e new research is reported in the September issue ...wn that the mutation frequently occurs in the most...
...Sept. 5, 2007) As if being admitted to the hospit... at higher risk of becoming infected with a superb.... The toxins produced by C. difficile kill human i...owing the bacteria to use them as fuel. This resul...braham Linc Sonenshein, PhD, and colleagues from t...
...ynamic world of the developing brain, neural stem ...fluid-filled ventricles. These newborn neurons the...cortex, the seat of higher cognitive functions. No...his migration one that may also play an important...s, including cancer. , The finding, the cover st...
Other Biology News:Presence of gene mutation helps guide thyroid cancer treatment 2Presence of gene mutation helps guide thyroid cancer treatment 3Curbing C. difficile's toxin production 2Neural stem cell study reveals mechanism that may play role in cancer 2Neural stem cell study reveals mechanism that may play role in cancer 3Neural stem cell study reveals mechanism that may play role in cancer 4
(Date:11/24/2009)..., TSXVENTURE:HTL , TORONTO,Nov.24/PRNewswir...yCalottoCapitalInc.,aleadingproviderofadvancedlase...tilityclinicmarkets,todayreportedoperationalandfin...09. , ,Q32009Highlights,-Revenuewas$1.46millionc...was66.3percentcomparedwith66.1percentinQ3,2008,-Ne...
(Date:11/24/2009)..., REDWOODCITY,Calif.,Nov.24/PRNewswire-FirstCall...thatRandyScott,GenomicHealth,sExecutiveChairman,wi...erenceinNewYorkCityonTuesday,December1,2009at10:00...edwebcastofthepresentation,visittheInvestorRelatio...r.genomichealth.com .Pleaseconnecttothewebsiteatle...
(Date:11/24/2009)... Chemical Abstracts Service (...eports that China,s patent office is now the world...ns in chemistry. China trailed Japan,s patent offi...WIPO), and the United States Patent and Trademark ...the USPTO in 2005, WIPO in 2006, and exceeded Japa...
(Date:11/23/2009)...AMPAIGN, Ill. You can think of it as origami ver...ity of Illinois have developed a technique for fab...icon structures from thin films by coupling photol...pillary interactions. , The films, only a few mic...ot possible with thicker pieces of the same materi...
Breaking Biology Technology:Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Genomic Health to Present at Piper Jaffray Health Care Conference 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3Water droplets direct self-assembly process in thin-film materials 2
...CHICAGO, Aug. 6 Advanced Life Sciences,Holdings, ... engaged in the,discovery, development and commerc... of infection, cancer and respiratory diseases tod...nd webcast discussing the,Company,s 2008 second qu...0,a.m. (EDT). Michael T. Flavin, Ph.D., Chairman &...
...QUEBEC CITY, Aug. 5 /PRNewswire-FirstCall/ - AEter...bal biopharmaceutical company focused on,endocrine...arter 2008,financial and operating results after m...y will host a conference call and webcast to discu... Eastern Time., Participants may access the confe...
...Leading Non-Fusion Spine Surgeon Supports Company,...search, Education, SAN DIEGO, Aug. 6 SpineMark C...t partners with hospitals and physicians to,develo...l education,training centers, has appointed Dr. Ru...(Bogen, Germany), as chairman of its International...
Other Biology Technology:Advanced Life Sciences To Host 2008 Second Quarter Financial Results Conference Call and Webcast 2Advanced Life Sciences To Host 2008 Second Quarter Financial Results Conference Call and Webcast 3SpineMark Appoints Dr. Rudolf Bertagnoli Chairman of International Medical Advisory Board 2
Chicken Anti-Human QPRT Polyclonal Antibody, Unconjugated from ProSci, Inc
Anti-J Chain Monoclonal Antibody, Unconjugated, Clone M19/9J from CHEMICON
Agarose from BioPioneer
... tissue sections and cell preparations immunohisto...ol soluble OR alcohol insoluble end products. Ul...Fast Red or AEC that require an aqueous mounting m...ng is required prior to use. This product is optim...
Biology Products: